Skip to main content
Clinical Trials/CTRI/2024/09/073718
CTRI/2024/09/073718
Recruiting
Phase 3

A Pragmatic Randomized Controlled Trial to assess the effectiveness and cost-effectiveness of Yoga for Antenatal Depression in Maharashtra, India (PRAGYA).

DBT-Wellcome Trust India Alliance1 site in 1 country336 target enrollmentStarted: September 20, 2024Last updated:

Overview

Phase
Phase 3
Status
Recruiting
Sponsor
DBT-Wellcome Trust India Alliance
Enrollment
336
Locations
1
Primary Endpoint
Depression during pregnancy is the primary

Overview

Brief Summary

A Pragmatic Randomized Controlled Trial to assess the effectiveness and cost-effectiveness of Yoga for Antenatal Depression in Maharashtra, India (PRAGYA).

Trial Design:

Pragmatic, single-blind, individual randomized, parallel-group, superiority trial with 1:1 allocation ratio.

Primary Objectives:

  1. To assess the effectiveness of the Yoga-Sanskar intervention on the severity of antenatal depression.

  2. To assess the cost-effectiveness of the Yoga-Sanskar intervention for antenatal depression

Secondary Objectives:

  1. To assess the effectiveness of the Yoga-Sanskar intervention on anxiety, stress, and quality of life (secondary outcomes) during pregnancy.

  2. To assess the effectiveness of the Yoga-Sanskar intervention on pregnancy outcomes (preterm labor, type of delivery, birthweight, and post-partum depression).

 Hypothesis:

Women with antenatal depression who practice yoga for three months during pregnancy will show greater reduction in the severity of depression measured using the Patient Health Questionnaire-9 compared to women with antenatal depression receiving Enhanced Usual Care.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 49.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Adult pregnant women above 18 years of age Gestational age between 12–26 weeks Patient Health Questionnaire-9 (PHQ-9) score of 10 or more Planning to stay in the study area throughout study duration (approximately four months).

Exclusion Criteria

  • Pregnant women advised rest/restriction of physical activities/laborious tasks by their obstetrician due to medical/obstetric problems History of recurrent spontaneous abortions (three or more) History of cervical stitch/encirclage operation History of pre-term labor/premature rupture of members Multiple pregnancy (triplet or more) Receiving treatment for mental health condition like schizophrenia, bipolar disorder Severe depression (score of 20 or above on PHQ-9) Presence of death wish/ suicidal thoughts almost every day (score of 3 on PHQ9 item 9) Inability to communicate in Marathi language Inability to attend in-person yoga sessions.

Outcomes

Primary Outcomes

Depression during pregnancy is the primary

Time Frame: Baseline, 6 weeks post-randomization, three-months post-randomization, post-delivery.

outcome to assess the effectiveness of the

Time Frame: Baseline, 6 weeks post-randomization, three-months post-randomization, post-delivery.

intervention. We will assess depression using a

Time Frame: Baseline, 6 weeks post-randomization, three-months post-randomization, post-delivery.

culturally adapted and validated Marathi version

Time Frame: Baseline, 6 weeks post-randomization, three-months post-randomization, post-delivery.

of PHQ-9.

Time Frame: Baseline, 6 weeks post-randomization, three-months post-randomization, post-delivery.

Secondary Outcomes

  • Anxiety (measured using the Marathi version of the Generalized Anxiety Disorder-7)

Investigators

Sponsor
DBT-Wellcome Trust India Alliance
Sponsor Class
Government funding agency
Responsible Party
Principal Investigator
Principal Investigator

Rahul Shidhaye

Pravara Institute of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials